Placenta Percreta With Bladder Infiltration : A Case Report
DOI:
https://doi.org/10.25077/aoj.6.1.104-109.2022Abstract
Objective : To report a case of placenta percreta with bladder infiltration.
Method : Case reports.
Case :a 24-year-old female G2P1A0H1 gravid 26-27 weeks, placenta percreta with gross hematuria. The second pregnant patient was less months pregnant with the results of a fetal ultrasound examination with a placenta covering the uterine internum (OUI) and suspected of penetrating the uterine wall (percreta), and a cesarean hysterectomy was performed.
Discussion : The cause of placenta percreta is unknown, it is associated with several clinical risk factors like the previous cesarean, placenta previa, grand multiparity, and previous uterine curettage. The management of placenta percreta can be challenging because the loss occurs at two sites in labor. Refractory hematuria occurs in 25% of patients due to placenta percreta invasion of the bladder. Management involves a team of obstetricians, urologists, intensivists, and neonatologists. Treatment is preferably carried out in tertiary care where there is a definite stock of blood with adequate blood products, a fully equipped neonatal intensive care unit (NICU). Delivery may be considered at 34-35 weeks gestation if there is no maternal and fetal deterioration because the incidence of antepartum hemorrhage appears to increase sharply at 36 weeks.
Conclusion : Management is recommended for placenta percreta cases, planning for premature cesarean hysterectomy with placenta left in situ. However, the diagnosis is made based on the results of the anatomic pathology obtained after hysterectomy, and is not considered a first-line treatment for women who still wish to maintain future fertility.
Keywords:placenta percreta, cesarean hysterectomyReferences
Fitzpatrick, Kathryn E et al. “Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study.†PloS one vol. 7,12 (2012): e52893.
Ibrahim MA, Liu A, Dalpiaz A, Schwamb R, Warren K, Khan SA. Urological manifestations of placenta percreta. Curr Urol 2015;8:57-65
Konijeti, Ramdev et al. “Placenta percreta and the urologist.†Reviews in urology vol. 11,3 (2009): 173-6.
Tillu, Neeraja et al. “Placenta percreta with bladder invasion: The armamentarium available in its management.†Urology annals vol. 11,3 (2019): 324-327.
Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta. Acta Obstet Gynecol Scand Wiley. 2013;92:1125–34
Banu H, Hui JW, Hui L, Hua L. Central placenta previa with placenta percreta partially invading bladder: a case report. Int J Reprod Contracept Obstet Gynecol 2015;4:859-62
Wagaskar VG, Daga SO, Patwardhan SK. Placenta percreta presenting with delayed haematuria. J Clin Diagn Res. 2015;9:PD01–2.
Koukoura O, Lialios G, Garas A, Sveronis G, Nidimos A, Gkorezi I, Alevra Z, Tzortzis V, Oeconomou A, Zachos I, Daponte A. Macroscopic Hematuria due to Placenta Percreta: Report of Two Cases and Short Review. Case Rep Obstet Gynecol. 2017;2017:9863792.
GuptaP, PradeepY, Goel A,SinghR. Hematuria: An Unusual Presentation of Placenta Percreta. Urology. 2012. 80(2): e13–e14.
Kayem G, Deneux-Tharaux C, Sentilhes L, PACCRETA group. PACCRETA: clinical situations at high risk of placenta ACCRETA/percreta: impact of diagnostic methods and management on maternal morbidity. Acta Obstet Gynecol Scand. 2013; 92: 476– 82.
Esakoff TF, Handler SJ, Granados JM, Caughey AB. PAMUS: placenta accreta management across the United States. J Matern Fetal Neonatal Med. 2012; 25: 761– 5.
Hayes E, Ayida G, Crocker A. The morbidly adherent placenta: diagnosis and management options. Curr Opin Obstet Gynecol. 2011; 23: 448– 53.13.
Sentilhes L, Descamps P, Goffinet F. Arteriovenous malformation following conservative treatment of placenta percreta with uterine artery embolization but no adjunctive therapy. Am J Obstet Gynecol. 2011; 205: e13.
Bouvier A, Sentilhes L, Thouveny F, Bouet PE, Gillard P, Willoteaux S, et al. Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. Clin Radiol. 2012; 67: 1089– 94.
Alanis M, Hurst BS, Marshburn PB, Matthews ML. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril. 2006; 86: 1514. e3–7.
Wang Z, Li X, Pan J, Zhang X, Shi H, Yang N, Jin Z. Uterine Artery Embolization for Management of Primary Postpartum Hemorrhage Associated with Placenta Accreta. Chin Med Sci J. 2016 Nov 20;31(4):228-232.
Chen C, Lee SM, Kim JW, Shin JH. Recent Update of Embolization of Postpartum Hemorrhage. Korean J Radiol. 2018 Jul-Aug;19(4):585-596. doi: 10.3348/kjr.2018.19.4.585. Epub 2018 Jun 14.
Dhinaharan P, Khrishnamoorthy S, Rajamanickam G M, Reddy K S, Pargal R. Placenta Percreta with urinary bladder infiltration : a modified posterior approach a case report and lessons learnt. International Journal of Scientific Study. 2018. p:134-6.
Tillu N, Savalia A, Patwardhan Sujata, Bhushan P. Placenta percreta with bladder invasion : The armamentarium available in its management. Urology Annals. 2019. p: 324-7.
Torrez-Morales F, Briones-Garduno J. Clinical case : Placenta percreta with bladder and rectum invasion. Circen. 2016.. p:1-4.
Abbas A, Ali S E, Michael A, Ali S.Successful fertility-preserving management of a case of placenta percreta invading the urinary bladder and anterior abdominal wall: A case report. Middle East Fertility Society Journal. 2018. p: 77-80.
Lialios G, Garas A, Sveronis G, Nidimos A,Gkorezi I, Alevra ZV, et al. Macroscopic hematuria due to placenta percreta : Report of two cases and short review. Hindawi Case Reports in Obstetrics and Gynecology. 2017.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Bayu Permana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Authors who publish with this journal agree to the following terms:
- Authors retain the copyright of published articles and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
License:
Andalas Obstetrics and Gynecology Journal (AOJ) is published under the terms of the Creative Commons Attribution 4.0 International License. This license permits anyone to copy and redistribute this material in any form or format, compose, modify, and make derivatives of this material for any purpose, including commercial purposes, as long as they credit the author for the original work.